Gain Therapeutics, Inc. (GANX)
NASDAQ·Healthcare·Biotechnology
$1.19
—
Mkt Cap $55.02M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (5 analysts)
$7.80
Range $4.00 – $10.00
Implied Upside
+555.5%
Consensus $7.80 vs current $1.19
NASDAQ·Healthcare·Biotechnology
$1.19
—
Mkt Cap $55.02M
Buy
5
Hold
0
Sell
0
Price Target (5 analysts)
$7.80
Range $4.00 – $10.00
+555.5%
Consensus $7.80 vs current $1.19